HAE 84.92 (+0.11%)
US4050241003Medical Devices & InstrumentsMedical Instruments & Supplies

Haemonetics (HAE) Stock Highlights

84.92 | +0.11%
2024-11-21 01:54:26
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Statistics

Range Today
83.32 85.33
Volume Today 618K
Range 1 Year
70.25 97.97
Volume 1 Year 132.5M
Range 3 Year
43.5 97.97
Volume 3 Year 337.07M
Range 10 Year
25.98 142.11
Volume 10 Year 1.12B

Highlights

Market Capitalization 4.39B (mid)
Floating Shares 50.68M
Current Price 84.92
Price To Earnings 38.62
Price To Revenue 3.71
Price To Book 4.63
Earnings Per Share 2.26
Payout Ratio 0%

Performance

Latest +0.11%
1 Month +11.21%
3 Months +13.65%
6 Months -10.69%
1 Year +1.07%
3 Years +50.57%
5 Years -29.44%
10 Years +131.64%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.